Literature DB >> 28522079

Sleep duration is associated with increased risk for cardiovascular outcomes: a pilot study in a sample of community dwelling adults in Ghana.

Helen V Cole1, Ellis Owusu-Dabo2, Juliet Iwelunmor3, Valerie Newsome4, Karlijn Meeks5, Charles Agyemang5, Girardin Jean-Louis4.   

Abstract

BACKGROUND: Associations between sleep duration and cardiovascular disease (CVD) risk factors have been demonstrated in past studies. However, previous studies have not investigated these relationships using objective sleep measures in sub-Saharan Africa. Our objective was to investigate the association between sleep duration and cardiovascular risk factors in a sample of community-dwelling Ghanaian adults.
METHODS: We used wrist actigraphy along with a seven-day sleep diary to measure sleep duration, wake after sleep onset, sleep latency, and sleep quality. Participants were randomly selected from among those participating in the RODAM study in rural and urban Ghana. Outcome measurements included 10-year risk of CVD events, prevalent CVD, and metabolic syndrome. Additional participant characteristics were assessed using a structured questionnaire. Linear and logistic regression analyses were used to assess the relationships between sleep measures and CVD risk.
RESULTS: A total of 263 participants from rural and urban Ghana participated. Total sleep time was positively associated with a 10-year CVD risk; this association remained after adjusting for age, sex, urban vs rural location, socio-economic status, physical activity, and sleep disturbance (β = 0.990, p = 0.015). Short sleep, defined as sleeping less than seven hours per night on average, was negatively associated with a 10-year CVD risk, and this relationship remained in the fully adjusted model (β = -2.100, p = 0.011). Sleep duration was not associated with prevalence of CVD or metabolic syndrome.
CONCLUSION: Using actigraphy to measure sleep duration among a population of community-dwelling adults in sub-Saharan Africa is feasible. We found a positive association between sleep and CVD risk. No association was found between sleep duration and prevalent CVD or metabolic syndrome. The implications and new directions relating to these findings are stated.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiovascular risk; Sleep duration; Sub-Saharan Africa

Mesh:

Year:  2017        PMID: 28522079     DOI: 10.1016/j.sleep.2017.03.008

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  5 in total

1.  Delayed Sleep Time in African Americans and Depression in a Community-Based Population.

Authors:  Omavi Bailey; Daniel Combs; Maria Sans-Fuentes; Cody M Havens; Michael A Grandner; Chithra Poongkunran; Sarah Patel; Sarah Berryhill; Natalie Provencio; Stuart F Quan; Sairam Parthasarathy
Journal:  J Clin Sleep Med       Date:  2019-06-15       Impact factor: 4.062

2.  Descriptive epidemiology of objectively-measured, free-living sleep parameters in a rural African setting.

Authors:  Ian Cook; Matlawa Mohlabe; Marianne Alberts
Journal:  BMC Res Notes       Date:  2020-07-01

3.  Self-Reported Sleep Duration and Its Correlates with Sociodemographics, Health Behaviours, Poor Mental Health, and Chronic Conditions in Rural Persons 40 Years and Older in South Africa.

Authors:  Karl Peltzer; Supa Pengpid
Journal:  Int J Environ Res Public Health       Date:  2018-06-28       Impact factor: 3.390

Review 4.  A Review of the Literature Regarding Sleep and Cardiometabolic Disease in African Descent Populations.

Authors:  Peter L Whitesell; Jennifer Obi; Nuri S Tamanna; Anne E Sumner
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-11       Impact factor: 5.555

5.  Sleep and Economic Status Are Linked to Daily Life Stress in African-Born Blacks Living in America.

Authors:  Zoe C Waldman; Blayne R Schenk; Marie Grace Duhuze Karera; Arielle C Patterson; Thomas Hormenu; Lilian S Mabundo; Christopher W DuBose; Ram Jagannathan; Peter L Whitesell; Annemarie Wentzel; Margrethe F Horlyck-Romanovsky; Anne E Sumner
Journal:  Int J Environ Res Public Health       Date:  2022-02-23       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.